WHO ICTRP trial
A multi-center, randomized, open label, controlled, trial for locally advanced…
ChiCTR1900027354 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900027354 |
|---|---|
| Public title | A multi-center, randomized, open label, controlled, trial for locally advanced inoperable lung squamous cell carcinoma with radiotherapy combined with EP regimen and EP combined with glycididazole sodium (Shimena) |
| Scientific title | A multi-center, randomized, open label, controlled, trial for locally advanced inoperable lung squamous cell carcinoma with radiotherapy combined with EP regimen and EP combined with glycididazole sodium (Shimena) |
| Primary sponsor | Liaoning Cancer Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Local advanced lung squamous cell carcinoma |
| Interventions | experimental group:radiotherapy, EP regimen combined with glycididazole sodium (Shimena);control group: radiotherapy combined with EP regimen |
| Registration date | Nov 10, 2019 |
| Target size | experimental group:60;control group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: